ArticleMolecular medicine (Cambridge, Mass.)2026
Galectin-3 associates with NF-κB activation and mitochondrial redox-related protein signatures in catecholamine-induced stress cardiomyopathy.
Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute catecholamine-induced myocardial stress contributes to several cardiac conditions, including takotsubo syndrome (TS), a life-threatening acute cardiac syndrome characterized by transient regional left ventricular dysfunction that lacks evidence-based therapy. Extracellular vesicles (EVs) reflect active cellular stress signaling and enable region-specific analysis of myocardial stress responses to acute injury. Galectin-3 (Gal-3) regulates inflammation and myocardial remodeling and predicts adverse outcomes in myocardial infarction and heart failure, yet its role in catecholamine-driven stress cardiomyopathy, including TS, remains unclear.
objectivesTo characterize regional myocardial stress signaling after catecholamine exposure using cardiac EV proteomics and to determine whether Gal-3–linked stress pathways are associated with the TS-like apical akinesia phenotype. METHODS AND
resultsCatecholamine-induced stress was induced in rats by isoprenaline administration and cardiac function was evaluated by echocardiography. EVs were isolated from apical and basal regions of the left ventricular myocardium using enzymatic digestion, differential centrifugation, and iodixanol purification. EVs were characterized by transmission electron microscopy, western blotting, and nanoparticle tracking analysis. EV protein abundance was quantified using TMTpro 18-plex LC–MS/MS and analyzed for stress and region-specific differences. EV proteomics analysis showed significant enrichment of Gal-3 in EVs isolated from the apical left ventricular myocardium after catecholamine stress and associated Gal-3 with inflammatory (TNF/TLR4-NF-κB-related) and mitochondrial and redox-related signatures. In cardiomyoblasts, recombinant Gal-3 increased NF-κB p65 Ser536 phosphorylation and reduced expression of antioxidant (Sod3) and mitochondrial biogenesis related (Ppargc1a) transcripts, while inhibition of Gal-3 attenuated TNF-α-induced NF-κB activation and suppressed isoprenaline-induced inflammatory gene expression. In vivo, myocardial Gal-3 increased after isoprenaline exposure, but did not differ between animals with or without TS-like apical akinesia, suggesting association with neurohumoral stress exposure rather than the TS-like contractile phenotype.
conclusionsGal-3 is upregulated following acute catecholamine exposure and is associated with inflammatory and mitochondrial redox signaling during myocardial stress. Although myocardial Gal-3 increased after isoprenaline exposure it was not associated with the TS-like contractile phenotype, indicating that Gal-3 reflects catecholamine-induced myocardial stress rather than determining regional contractile dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.